Liver Metastasis Unknown Status Phase 2 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0029622 (Liver Metastasis)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01511146Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid TumorTreatment